Research progress of radiation recall pneumonitis caused by immune checkpoint inhibitors / 国际肿瘤学杂志
Journal of International Oncology
; (12): 577-580, 2022.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-954326
Biblioteca responsável:
WPRO
ABSTRACT
At present, tumor therapy has entered the era of immunotherapy. However, in recent years, it has been found that the application of immune checkpoint inhibitors after chest radiotherapy can not only play a synergistic anti-tumor effect, but also cause radiation recall pneumonitis (RRP). RRP is a rare immune-related adverse reaction, which even leads to death in severe cases. It is of great significance to study the mechanisms and influencing factors of RRP caused by immune checkpoint inhibitors for strengthening the cognitive management of RRP and reducing the risk of RRP.
Texto completo:
Disponível
Contexto em Saúde:
ODS3 - Meta 3.3 Acabar com as doenças tropicais negligenciadas e combater as doenças transmissíveis
/
ODS3 - Meta 3.4 Reduzir as mortes prematuras devido doenças não transmissíveis
Problema de saúde:
Pneumonía
/
Outras Doenças Respiratórias
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Journal of International Oncology
Ano de publicação:
2022
Tipo de documento:
Artigo